PatentSight is proud to announce that our patent analytics software is now a patent protected Intellectual Property. In August, 2019, the USPTO officially granted Nils Omland, our founder and CEO, with a patent for the PatentSight Business Intelligence software solution. Back in 2018, when LexisNexis® acquired PatentSight, this patent was still undergoing review. The granting of this patent makes our SaaS offering, officially, one of its kind.
In September 2016, the German drugs and chemicals group Bayer announced its intention to acquire the multinational Monsanto, known for its Roundup herbicide and GMOs. This merger would produce the world’s most powerful company in the seed and pesticide industry. On 21 March 2018 the EU commission released a Press Release announcing their approval of the acquisition of Monsanto by Bayer. The merger was approved on the conditional divestiture of an extensive remedy package, which addresses the parties' overlaps in seeds, pesticides and digital agriculture. It is for determining such inconspicuous aspects of a merger, like technology overlap, that the EU commission relied on the LexisNexis® PatentSight® database and our award-winning Business Intelligence software solution.
From recent news reports it became clear that China accounts for almost 90% of the world’s production and supply of the so-called Rare Earth Elements (REE). These are a group of 17 elements that are not commonly found in the earth's surface. For e.g. Scandium, one of the rare earth elements, is heavily used in manufacturing parts for the aerospace industry. Similarly, these elements have varied and extremely specific uses, for which, at least for the time-being, no viable substitutes can be sourced. We used our excellent patent database and scientifically proven metrics to analyze the current situation around rare earth elements from a patent quality point of view to identify possible opportunities and threats in this business.
Since 2010 Amazon has grown its patent portfolio from less than 1,000 active patents in 2010 to nearly 10,000 in 2019, a ten-fold increase in less than a decade.
Amazon heavily cites Microsoft, IBM, and Alphabet, with 39%, 32% and 28% of Amazon’s total Patent Asset Index
Amazon’s patent portfolio is dominated by Cloud Computing, with the majority of the patents contributing to AWS’ current and future services roadmap. AWS achieved 41% year-over-year revenue growth in the latest fiscal quarter, reaching $7.6B in revenue.
“我看到三星手機上有一些不錯的功能，希望 iPhone 也能具備。希望蘋果願意並且能夠使用這些功能，但我不知道三星是否會阻止我們。”
- Steve Wozniak
近年來，智慧手機行業一直以驚人的速度發展，主要製造商每年都會發佈更新和升級的旗艦智慧手機。在這場勢均力敵的技術競賽中，沒有人知道誰會勝出，也沒有人知道哪款產品會成為下一代 iPhone X 或 Galaxy Fold。對於外界而言，這個行業似乎發展快速，但如果瞭解專利的開發情況，便會發現這是 20 多年來逐步發展的結果。近期，三星、蘋果和其他主要廠商紛紛宣告準備推出折疊面板智慧手機，這引發人們對這行業新的猜測。
“There are good things I see on Samsung phones that I wish were in my iPhone. I wish Apple would use them and could use them, and I don't know if Samsung would stop us."
- Steve Wozniak
The smartphone industry has been evolving at break-neck speed, of late, with key players releasing updated and upgraded flagship smartphones every year. This technology race is close, and there is no telling who will succeed or which product will be the next iPhone X or Galaxy fold. To the rest of the world, this industry and its developments may seem fast but if you look at patent developments, you will realize that this has been happening gradually over more than 2 decades. With the most recent announcements from Samsung, Apple and other major players, all getting ready to launch foldable display smartphones, the industry is abuzz with new speculation.
So far, not much information is available about where these key players are at, in developing this new form of smartphone display technology. There is speculation that foldable smart phones are just around the corner, but no real world development has happened, nor is the technological aspects of the product overtly discussed. In such a situation, patent data analysis is one of the most reliable and insightful methods that can shed light into this otherwise unclear technology space.
"Success in creating AI would be the biggest event in human history. Unfortunately, it might also be the last, unless we learn how to avoid the risks."
- Stephen Hawking
Despite its wide-spread adoption and further sub-technologies being developed over the years, the field of AI has remained murky to outsiders. For generations, Artificial Intelligence or AI has been depicted to the general public as a threat to our existence or as a superior being which deems our species unworthy of the planet. There exists a definite lack of precise definition of the field and there is little, to no information regarding where the world nations are at with respect to developing the technology.
In pursuit of enhancing the clarity on this topic, EconSight - a leading Switzerland-based Business Research and Consulting firm, partnered with PatentSight and the Swiss Federal Institute of Intellectual Property to conduct a deep-dive into the technology field of Artificial Intelligence. Kai Gramke, who is the CEO at EconSight, presented the findings from the study at the PatentSight Summit 2019.
“Being at least as good as the leader is a prerequisite to being competitive.”
— Peter Drucker
Among the various uses for the Patent Asset Index™, one major area of application is in portfolio Benchmarking. Any company operating in the modern day sets goals for themselves, to guide them towards the success that they strive to achieve. Our unparalleled data quality and multi-pronged analysis tools ensure that decision makers get the right information at the right time to make decisions about the right goals to set.
In a newly released whitepaper PatentSight takes a deep dive into the portfolio of Palantir – one of Silicon Valley’s most secretive companies – to demonstrate how advanced patent analytics can be used to provide critical insights for investment decisions.
Ranked among the top 10 global medical device companies as of revenue, General Electric is now about to file for an IPO to spin out its health-care unit GE Healthcare, as reported by CNBC. With the ongoing jump of Siemens Healthineers shares after their $5 Billion IPO, now GE Healthcare has caught the attention of investors in the medical device market. In this context, PatentSight shed light on the global top 10 medical device companies as of revenue in 2017 from a patent perspective.